X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (51) 51
female (36) 36
hematology (33) 33
male (32) 32
child (27) 27
infant (23) 23
child, preschool (21) 21
children (21) 21
index medicus (17) 17
infant, newborn (17) 17
treatment outcome (17) 17
adolescent (14) 14
cord blood transplantation (13) 13
oncology (13) 13
chemotherapy (12) 12
pediatrics (12) 12
japan (11) 11
recipients (9) 9
adult (8) 8
cancer (8) 8
disease-free survival (8) 8
hematopoietic stem cell transplantation (8) 8
transplantation (8) 8
acute lymphoblastic leukemia (7) 7
bone-marrow-transplantation (7) 7
medicine & public health (7) 7
recurrence (7) 7
retrospective studies (7) 7
bone-marrow transplantation (6) 6
leukemia (6) 6
mll gene rearrangement (6) 6
precursor cell lymphoblastic leukemia-lymphoma - genetics (6) 6
research (6) 6
risk factors (6) 6
survival rate (6) 6
translocation, genetic (6) 6
chromosome aberrations (5) 5
dna-binding proteins - genetics (5) 5
engraftment (5) 5
graft vs host disease - etiology (5) 5
hematopoietic stem cells (5) 5
histone-lysine n-methyltransferase (5) 5
middle aged (5) 5
myeloid-lymphoid leukemia protein (5) 5
oncology, experimental (5) 5
placental-blood (5) 5
precursor cell lymphoblastic leukemia-lymphoma - therapy (5) 5
prognosis (5) 5
remission induction (5) 5
stem cell transplantation (5) 5
stem cells (5) 5
acute myeloid leukemia (4) 4
acute myeloid-leukemia (4) 4
acute-leukemia (4) 4
age factors (4) 4
analysis (4) 4
antineoplastic agents - therapeutic use (4) 4
blood banks (4) 4
bone marrow (4) 4
bone-marrow (4) 4
childhood-leukemia (4) 4
cryopreservation (4) 4
follow-up studies (4) 4
health aspects (4) 4
hematopoietic stem cell transplantation - adverse effects (4) 4
high-dose cytarabine (4) 4
internal medicine (4) 4
leukemia, myeloid, acute - drug therapy (4) 4
medical colleges (4) 4
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (4) 4
stem-cells (4) 4
umbilical cord blood (4) 4
unrelated donor (4) 4
unrelated donors (4) 4
acute disease (3) 3
acute lymphoblastic-leukemia (3) 3
acute lymphocytic leukemia (3) 3
acute myelogenous leukemia (3) 3
adenine phosphoribosyltransferase - deficiency (3) 3
adenine phosphoribosyltransferase deficiency (3) 3
age (3) 3
aged (3) 3
alleles (3) 3
aml (3) 3
anemia (3) 3
animals (3) 3
antineoplastic combined chemotherapy protocols - administration & dosage (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
blood (3) 3
childrens cancer group (3) 3
cord blood bank (3) 3
cytogenetic analysis (3) 3
disease (3) 3
dose-response relationship, drug (3) 3
down syndrome (3) 3
drug administration schedule (3) 3
expression (3) 3
fetal blood (3) 3
fetal blood - transplantation (3) 3
flow cytometry (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Pediatrics International, ISSN 1328-8067, 06/2018, Volume 60, Issue 6, pp. 569 - 575
Journal Article
Journal Article
Pediatrics International, ISSN 1328-8067, 06/2019, Volume 61, Issue 6, pp. 566 - 571
Background The prognosis of high‐risk neuroblastoma stage 4 with bone marrow metastasis, MYCN amplified, or refractory neuroblastoma is poor. To date, no... 
neuroblastoma | killer‐cell immunoglobulin‐like receptor | cord blood transplantation | killer-cell immunoglobulin-like receptor | STAGE-4 NEUROBLASTOMA | BONE-MARROW-TRANSPLANTATION | PHASE-II | PROGNOSTIC VALUE | LESION | CHEMOTHERAPY | CHILDREN | GENOTYPES | KIR | DISEASE | PEDIATRICS | Adrenal Gland Neoplasms - immunology | Humans | Retroperitoneal Neoplasms - therapy | Child, Preschool | Male | Neuroblastoma - therapy | Retroperitoneal Neoplasms - immunology | Cord Blood Stem Cell Transplantation - methods | Mediastinal Neoplasms - pathology | Mediastinal Neoplasms - therapy | Neuroblastoma - immunology | Biomarkers | Female | Ligands | Mediastinal Neoplasms - immunology | Retroperitoneal Neoplasms - pathology | Receptors, KIR - immunology | Adrenal Gland Neoplasms - pathology | Neuroblastoma - pathology | Adrenal Gland Neoplasms - therapy | Medical research | Chemotherapy | Stem cells | Medicine, Experimental | Transplantation | Metastasis | Neuroblastoma | Radiotherapy | Hematopoietic stem cells | Cancer | Graft-versus-host reaction | Adrenal glands | Mediastinum | Glands | Radiation | Stem cell transplantation | Hemorrhage | Blood | Metastases | Cord blood | Surgery | Melphalan | Peripheral blood | Bone marrow | Remission | Busulfan | Cystitis | Autografts | Immunoglobulins | Complications | Histology | Radiation therapy | Patients | Disease control | Amplification | Retroperitoneum | Refractory materials | Medical prognosis | Hemorrhagic cystitis | Index Medicus
Journal Article
Pediatrics International, ISSN 1328-8067, 10/2017, Volume 59, Issue 10, pp. 1046 - 1052
Background The combination of fludarabine (Flu), high‐dose cytarabine (Ara‐C) and granulocyte colony‐stimulating factor (G‐CSF; FLAG), with anthracyclines has... 
FLAG‐IDA | minimal residual disease | acute myeloid leukemia | children | relapse | FLAG-IDA | CYTOSINE-ARABINOSIDE | BONE-MARROW-TRANSPLANTATION | ACUTE MYELOGENOUS LEUKEMIA | RANDOMIZED-TRIAL | HIGH-DOSE CYTARABINE | G-CSF | LIPOSOMAL DAUNORUBICIN | PHASE-II TRIAL | INITIAL THERAPY | PEDIATRICS | Recombinant Proteins - therapeutic use | Recurrence | Drug Administration Schedule | Cytarabine - therapeutic use | Humans | Child, Preschool | Male | Treatment Outcome | Antineoplastic Agents - therapeutic use | Vidarabine - analogs & derivatives | Vidarabine - therapeutic use | Granulocyte Colony-Stimulating Factor - therapeutic use | Young Adult | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Leukemia, Myeloid, Acute - drug therapy | Female | Child | Idarubicin - therapeutic use | Relapse | Chemotherapy | Anthracyclines | Granulocyte colony-stimulating factor | Influenza | Meningitis | Transplantation | Hematopoietic stem cells | Diseases | Cancer | Flow cytometry | Toxicity | Leukemia | Stem cell transplantation | Cerebrospinal fluid | Cytarabine | Granulocytes | Bone marrow | Remission | Bacteria | Colony-stimulating factor | Children | Hematology | Colonies | Myeloid leukemia | Medical treatment | Minimal residual disease | Wilms' tumor | Patients | Lymphoma | Hemopoiesis | Cytometry | Fludarabine | Anthracycline | Fatalities | Adults | Leukocytes (granulocytic) | Acute myeloid leukemia
Journal Article
Journal Article
SAGE Open Medical Case Reports, ISSN 2050-313X, 1/2018, Volume 6, p. 2050313X17753788
Wiskott–Aldrich syndrome is a rare X-linked recessive disease resulting from variations in the WAS gene. Wiskott–Aldrich syndrome is sometimes difficult to... 
Cytomegalovirus | Infections
Journal Article
Journal Article
Journal Article
CEN Case Reports, ISSN 2192-4449, 5/2016, Volume 5, Issue 1, pp. 34 - 39
Recently, a number of methods have been devised for detection of mutations in the field of molecular genetics. The LightCycler system has been used for rapid... 
Nephrology | Medicine & Public Health | Urolithiasis | LightCycler | Adenine phosphoribosyltransferase deficiency | Real-time PCR instruments | Child | Urology | 2,8-Dihydroxyadeninuria
Journal Article
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, ISSN 1936-2625, 2018, Volume 11, Issue 5, pp. 2419 - 2429
Objectives: Interleukin-(IL-)17-mediated cells contribute to the imbalance of cellular immunity in the pathogenesis of immune thrombocytopenia (ITP). We... 
monocytes | CELLS | CD163 | ITP | PURPURA | Immune thrombocytopenia | PATHOLOGY | PATHOGENESIS | interleukin-17 | macrophages | ONCOLOGY | DISEASE | ELTROMBOPAG | CD68 | TH17
Journal Article
Journal Article
Journal Article
Journal of Molecular Medicine, ISSN 0946-2716, 1/2011, Volume 89, Issue 1, pp. 43 - 50